Laporan laba rugi Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare · Biotechnology · Karyawan: 507 · CEO: Grant E. Pickering
- Harga
- $62,03 -0,93%
- Kapitalisasi pasar
- $9,76 M
- Nilai perusahaan
- $9,7 M
- Laporan terakhir
- Q2 '26 diajukan 2026-08-05
- Laporan berikutnya
- 2026-11-03 Estimasi EPS: -$2,11
Laporan laba rugi
| Laporan laba rugi | Tren | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beban pokok pendapatan | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4,99 jt | $0 | -$4,99 jt | $5,85 jt | $0 | |
| Laba kotor | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$4,99 jt | $0 | $4,99 jt | -$5,85 jt | $0 | |
| Riset & pengembangan | $97,4 jt | $104 jt | $94,6 jt | $132 jt | $117 jt | $134 jt | $148 jt | $194 jt | $210 jt | $242 jt | $313 jt | $268 jt | |
| Umum & administrasi | $15,6 jt | $17,5 jt | $19,9 jt | $21,5 jt | $23 jt | $28,6 jt | $32,7 jt | $32 jt | $32,4 jt | $32,2 jt | $33,1 jt | $34,9 jt | |
| Beban operasional lainnya | $0 | $75 jt | $0 | $0 | $0 | $0 | $0 | -$4,99 jt | $0 | $4,99 jt | -$5,85 jt | $0 | |
| Beban operasional | $113 jt | $197 jt | $114 jt | $153 jt | $140 jt | $162 jt | $181 jt | $221 jt | $242 jt | $279 jt | $340 jt | $303 jt | |
| Laba operasional | -$113 jt | -$197 jt | -$114 jt | -$153 jt | -$140 jt | -$162 jt | -$181 jt | -$226 jt | -$242 jt | -$274 jt | -$346 jt | -$303 jt | |
| Pendapatan bunga | $18,5 jt | $17,6 jt | $21,7 jt | $23,8 jt | $28,1 jt | $36,5 jt | $32,9 jt | $31,1 jt | $29,3 jt | $26,5 jt | $26,6 jt | $25,8 jt | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | -$1,64 jt | -$15,9 jt | -$19,5 jt | -$24,3 jt | -$292 rb | -$105 jt | -$40,1 jt | -$59,6 jt | -$29,6 jt | -$27,8 jt | -$25,2 jt | -$7,28 jt | |
| Total pendapatan non-operasional | $20,4 jt | $15,9 jt | $19,5 jt | $24,3 jt | $36,8 jt | $25,1 jt | $40,1 jt | $59,6 jt | $29,6 jt | $27,8 jt | $25,2 jt | $18,5 jt | |
| Laba sebelum pajak | -$92,7 jt | -$181 jt | -$95 jt | -$129 jt | -$103 jt | -$137 jt | -$141 jt | -$167 jt | -$213 jt | -$247 jt | -$321 jt | -$284 jt | |
| Laba bersih | -$92,7 jt | -$181 jt | -$95 jt | -$129 jt | -$103 jt | -$137 jt | -$141 jt | -$167 jt | -$213 jt | -$247 jt | -$321 jt | -$284 jt | |
| EPS (dasar) | -$0,91 | -$1,73 | -$0,85 | -$1,10 | -$0,83 | -$1,12 | -$1,04 | -$1,22 | -$1,56 | -$1,81 | -$2,30 | -$1,97 | |
| EPS (dilusian) | -$0,91 | -$1,73 | -$0,85 | -$1,10 | -$0,83 | -$1,12 | -$1,04 | -$1,22 | -$1,56 | -$1,81 | -$2,30 | -$1,97 | |
| Saham (dasar, rata-rata tertimbang) | 102 jt | 104 jt | 112 jt | 117 jt | 124 jt | 123 jt | 136 jt | 136 jt | 136 jt | 136 jt | 140 jt | 144 jt | |
| Saham (dilusian, rata-rata tertimbang) | 102 jt | 104 jt | 112 jt | 117 jt | 124 jt | 123 jt | 136 jt | 136 jt | 136 jt | 136 jt | 140 jt | 144 jt | |
| Depresiasi & amortisasi | $2,48 jt | $2,95 jt | $3,09 jt | $3,48 jt | $4,49 jt | $4,79 jt | $4,87 jt | $4,99 jt | $5,2 jt | $9,8 jt | $5,85 jt | $5,95 jt | |
| EBITDA | -$109 jt | -$178 jt | -$91,9 jt | -$125 jt | -$135 jt | -$52,6 jt | -$136 jt | -$162 jt | -$208 jt | -$237 jt | -$315 jt | -$290 jt |
| Laporan laba rugi | Tren | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beban pokok pendapatan | $0 | $1,04 jt | $1,23 jt | $1,41 jt | $0 | $0 | $0 | $0 | $0 | |
| Laba kotor | $0 | -$1,04 jt | -$1,23 jt | -$1,41 jt | $0 | $0 | $0 | $0 | $0 | |
| Riset & pengembangan | $12,8 jt | $30,1 jt | $45,6 jt | $73,6 jt | $78,4 jt | $169 jt | $332 jt | $477 jt | $794 jt | |
| Umum & administrasi | $5,05 jt | $5,39 jt | $0 | $0 | $25,3 jt | $39,8 jt | $60,7 jt | $92,9 jt | $129 jt | |
| Beban operasional lainnya | $0 | $5,18 jt | $0 | $0 | $0 | $23 jt | $75 jt | $0 | $0 | |
| Beban operasional | $17,4 jt | $35,5 jt | $52,9 jt | $88,2 jt | $104 jt | $232 jt | $468 jt | $570 jt | $924 jt | |
| Laba operasional | -$17,8 jt | -$35,5 jt | -$54,2 jt | -$89,6 jt | -$104 jt | -$232 jt | -$468 jt | -$570 jt | -$924 jt | |
| Pendapatan bunga | $164 rb | $903 rb | $632 rb | $244 rb | $344 rb | $8,36 jt | $62,9 jt | $110 jt | $120 jt | |
| Beban bunga | $0 | $75 rb | $40 rb | $7 rb | $7 rb | $2 rb | $0 | $0 | $0 | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | $0 | -$6,12 jt | -$3,92 jt | -$371 rb | -$3,6 jt | -$8,77 jt | -$65,8 jt | -$106 jt | -$157 jt | |
| Total pendapatan non-operasional | $595 rb | $6,05 jt | $3,88 jt | $364 rb | $3,59 jt | $8,77 jt | $65,8 jt | $106 jt | $157 jt | |
| Laba sebelum pajak | -$17,2 jt | -$29,5 jt | -$50,3 jt | -$89,2 jt | -$100 jt | -$223 jt | -$402 jt | -$464 jt | -$767 jt | |
| Laba bersih | -$17,2 jt | -$29,5 jt | -$50,3 jt | -$89,2 jt | -$100 jt | -$223 jt | -$402 jt | -$464 jt | -$767 jt | |
| EPS (dasar) | -$4,84 | -$8,12 | -$14,10 | -$2,97 | -$1,93 | -$3,44 | -$4,14 | -$3,80 | -$5,63 | |
| EPS (dilusian) | -$4,83 | -$8,12 | -$14,10 | -$2,97 | -$1,93 | -$3,44 | -$4,14 | -$3,80 | -$5,63 | |
| Saham (dasar, rata-rata tertimbang) | 3,57 jt | 3,63 jt | 3,8 jt | 29,5 jt | 51,9 jt | 64,9 jt | 97,2 jt | 122 jt | 136 jt | |
| Saham (dilusian, rata-rata tertimbang) | 3,57 jt | 3,63 jt | 3,8 jt | 29,5 jt | 51,9 jt | 64,9 jt | 97,2 jt | 122 jt | 136 jt | |
| Depresiasi & amortisasi | $625 rb | $1,04 jt | $1,23 jt | $1,41 jt | $3,46 jt | $9,45 jt | $10,2 jt | $15,8 jt | $24,9 jt | |
| EBITDA | -$17,2 jt | -$28,4 jt | -$49 jt | -$87,8 jt | -$96,6 jt | -$214 jt | -$392 jt | -$448 jt | -$742 jt |
Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.
Pendapatan, laba operasional, dan pertumbuhan
kuartalanMargin
kuartalanBiaya sebagai % pendapatan
kuartalanLaporan lainnya
Sumber
Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data per 2026-11-02